Keyword: immune-oncology models
News
09.01.2025
-
In a move to expand its oncology business, GSK is nearing a $1 billion deal to buy a US biotech developing a treatment for rare gastrointestinal tumors.
News
10.02.2016
- The combination of two cancer drugs from UK-Swedish drugs maker AstraZeneca and its biologics research and development arm MedImmune could be a potential breakthrough in treating a...
News
24.10.2014
- US drug discovery and development service provider Crown Bioscience has opened a new research center at Kannapolis, North Carolina. The new center, which Crown said represents a...
